Time	time	O	O	O	O
course	course	O	O	O	O
of	of	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
in	in	O	O	O	O
puromycin	puromycin	O	O	O	O
aminonucleoside-induced	aminonucleoside-induced	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Reactive	reactive	CHEMICALS	O	OTHERS	I
oxygen	oxygen	CHEMICALS	O	OTHERS	I
species	species	CHEMICALS	O	OTHERS	I
have	have	O	O	O	O
been	been	O	O	O	O
implicated	implicated	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
pathogenesis	pathogenesis	O	O	O	O
of	of	O	O	O	O
acute	acute	O	O	O	O
puromycin	puromycin	CHEMICALS	O	OTHERS	I
aminonucleoside	aminonucleoside	CHEMICALS	O	OTHERS	I
(PAN)-induced	(pan)-induced	O	O	O	O
nephropathy	nephropathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
with	with	O	O	O	O
antioxidants	antioxidants	O	O	O	O
significantly	significantly	O	O	O	O
reducing	reducing	O	O	O	O
the	the	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
temporal	temporal	O	O	O	O
relationship	relationship	O	O	O	O
between	between	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
kidney	kidney	O	O	O	O
and	and	O	O	O	O
proteinuria	proteinuria	O	DISEASE	OTHERS	I
was	was	O	O	O	O
examined	examined	O	O	O	O
in	in	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
.	.	O	O	O	O

Rats	rats	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
single	single	O	O	O	O
IV	iv	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
puromycin	puromycin	CHEMICALS	O	OTHERS	I
aminonucleoside	aminonucleoside	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
(	(	O	O	O	O
PAN	pan	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
7.5	7.5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
24	24	O	O	O	O
hour	hour	O	O	O	O
urine	urine	O	O	O	O
samples	samples	O	O	O	O
were	were	O	O	O	O
obtained	obtained	O	O	O	O
prior	prior	O	O	O	O
to	to	O	O	O	O
sacrifice	sacrifice	O	O	O	O
on	on	O	O	O	O
days	days	O	O	O	O
3,5,7,10,17,27,41	3,5,7,10,17,27,41	O	O	O	O
(	(	O	O	O	O
N	n	O	O	OTHERS	I
=	=	O	O	O	O
5	5	O	O	O	O
-	-	O	O	O	O
10	10	O	O	O	O
per	per	O	O	O	O
group	group	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
kidneys	kidneys	O	O	O	O
were	were	O	O	O	O
removed	removed	O	O	O	O
,	,	O	O	O	O
flushed	flushed	O	O	O	O
with	with	O	O	O	O
ice	ice	O	O	O	O
cold	cold	O	O	O	O
TRIS	tris	O	O	O	O
buffer	buffer	O	O	O	O
.	.	O	O	O	O

Kidney	kidney	O	O	O	O
cortices	cortices	O	O	O	O
from	from	O	O	O	O
each	each	O	O	O	O
animal	animal	O	O	O	O
were	were	O	O	O	O
used	used	O	O	O	O
to	to	O	O	O	O
prepare	prepare	O	O	O	O
homogenates	homogenates	O	O	O	O
.	.	O	O	O	O

Tissue	tissue	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
was	was	O	O	O	O
measured	measured	O	O	O	O
in	in	O	O	O	O
whole	whole	O	O	O	O
homogenates	homogenates	O	O	O	O
as	as	O	O	O	O
well	well	O	O	O	O
as	as	O	O	O	O
in	in	O	O	O	O
lipid	lipid	O	O	O	O
extracts	extracts	O	O	O	O
from	from	O	O	O	O
homogenates	homogenates	O	O	O	O
as	as	O	O	O	O
thiobarbituric	thiobarbituric	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
reactive	reactive	CHEMICALS	O	OTHERS	I
substances	substances	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Proteinuria	proteinuria	O	DISEASE	OTHERS	I
was	was	O	O	O	O
evident	evident	O	O	O	O
at	at	O	O	O	O
day	day	O	O	O	O
5	5	O	O	O	O
,	,	O	O	O	O
peaked	peaked	O	O	O	O
at	at	O	O	O	O
day	day	O	O	O	O
7	7	O	O	O	O
and	and	O	O	O	O
persisted	persisted	O	O	O	O
to	to	O	O	O	O
day	day	O	O	O	O
27	27	O	O	O	O
.	.	O	O	O	O

Lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
in	in	O	O	O	O
homogenates	homogenates	O	O	O	O
was	was	O	O	O	O
maximal	maximal	O	O	O	O
at	at	O	O	O	O
day	day	O	O	O	O
3	3	O	O	O	O
and	and	O	O	O	O
declined	declined	O	O	O	O
rapidly	rapidly	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
levels	levels	O	O	O	O
by	by	O	O	O	O
day	day	O	O	O	O
17	17	O	O	O	O
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
supports	supports	O	O	O	O
the	the	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
lipid	lipid	O	O	O	O
peroxidation	peroxidation	O	O	O	O
in	in	O	O	O	O
mediating	mediating	O	O	O	O
the	the	O	O	O	O
proteinuric	proteinuric	O	O	OTHERS	I
injury	injury	O	O	OTHERS	I
in	in	O	O	O	O
PAN	pan	CHEMICALS	O	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

